Researcher
Ivan Van Riet
- Research Expertise:
- Bone marrow and peripheral blood stem cells: biology and therapeutical use
- Stem cell processing and banking
- Tumo-host interactions in blood cancer (multiple myeloma)
- Keywords:Medicine
- Disciplines:Agricultural, veterinary and food sciences, Social sciences, Natural sciences
- Users of research expertise:
- Bone marrow and peripheral blood stem cells: biology and therapeutical use
- Stem cell processing and banking
- Tumo-host interactions in blood cancer (multiple myeloma)
Affiliations
- Hematology (Department)
Member
From1 Jun 2010 → Today - Hematology (Research group)
Member
From1 Oct 1999 → Today - Basic (bio-) Medical Sciences (Department)
Member
From8 Apr 2019 → Today - Basic (bio-) Medical Sciences (Department)
Member
From1 Jan 2014 → 20 Oct 2022 - Immunology and Microbiology (Department)
Member
From1 Oct 2005 → 31 Dec 2013 - Immunology and Microbiology (Department)
Member
From1 Oct 2002 → 30 Sep 2005 - Immunology and Microbiology (Department)
Member
From1 Sep 1992 → 31 Aug 1993
Projects
1 - 2 of 2
- Tumor characterization and disease follow-up in multiple myeloma by (epi) genetic profiling using liquid biopsiesFrom1 Nov 2021 → TodayFunding: FWO junior postdoctoral fellowship
- Tumor-microenvoronment interactions in multiple myeloma: regulation by epigenetic modifications and hypoxia.From1 Jan 2010 → 31 Dec 2013Funding: FWO research project (including WEAVE projects)
Publications
1 - 10 of 20
- Intratumoral administration of the immunologic adjuvant AS01B in combination with autologous CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells plus ipilimumab and intravenous nivolumab in patients with refractory advanced melanoma(2024)
Authors: Jens Tijtgat, Xenia Geeraerts, Anais Boisson, Latoya Stevens, Manon Vounckx, Iris Dirven, Julia Katharina Schwarze, Steven Raeymaeckers, Ramses Forsyth, Ivan Van Riet, et al.
- Influence of in vitro expansion conditions on biological properties of bone marrow-derived mesenchymal stromal cells(2023)
Authors: Ann De Becker, Ivan Van Riet
Number of pages: 170 - Intratumoral administration of CD1c (BDCA-1)+ and CD141 (BDCA-3)+ myeloid dendritic cells in combination with talimogene laherparepvec in immune checkpoint blockade refractory advanced melanoma patients(2022)
Authors: Julia Katharina Schwarze, Jens Tijtgat, G Awada, Louise Cras, Angela Vasaturo, Christopher Bagnall, Ramses Forsyth, Inès Dufait, Sandra Tuyaerts, Ivan Van Riet, et al.
Pages: 1-13 - Oncolytic Herpes Simplex Virus Type 1 Induces Immunogenic Cell Death Resulting in Maturation of BDCA-1+ Myeloid Dendritic Cells(2022)
Authors: Philipp Kalus, Jolien De Munck, Sarah Vanbellingen, Laura Carreer, Thessa Laeremans, Katrijn Broos, Inès Dufait, Julia Katharina Schwarze, Ivan Van Riet, Bart Neyns, et al.
- Unraveling the Effects of a Talimogene Laherparepvec (T-VEC)-Induced Tumor Oncolysate on Myeloid Dendritic Cells(2021)
Authors: Jens Tijtgat, Jolien De Munck, Inès Dufait, Julia Katharina Schwarze, Ivan Van Riet, Lorenzo Franceschini, Karine Breckpot, Joeri L Aerts, Bart Neyns, Sandra Tuyaerts
- Validation of a PCR-based next-generation sequencing approach for the detection and quantification of minimal residual disease in acute lymphoblastic leukemia and multiple myeloma using gBlocks as calibrators(2021)
Authors: Jona Van der Straeten, Wouter De Brouwer, Emmanuelle Kabongo Kanjinga, Marie-Françoise Dresse, Karel Fostier, Rik Schots, Ivan Van Riet, M.H.C. Bakkus
Pages: 599-611 - Intratumoral Combinatorial Administration of CD1c (BDCA-1)+ Myeloid Dendritic Cells Plus Ipilimumab and Avelumab in Combination with Intravenous Low-Dose Nivolumab in Patients with Advanced Solid Tumors(2020)
Authors: Julia Katharina Schwarze, G Awada, Louise Cras, Jens Tijtgat, Ramses Forsyth, Inès Dufait, Sandra Tuyaerts, Ivan Van Riet, Bart Neyns
Pages: 1-16 - Providing both autologous and allogeneic hematopoietic stem cell transplants (HSCT) may have a stronger impact on the outcome of autologous HSCT in adult patients than activity levels or implementation of JACIE at Belgian transplant centres.(2019)
Authors: HA Poirel, Marijke Vanspauwen, Gilles Macq, Anke De Geyndt, Johan Maertens, Evelyne Willems, Dominik Selleslag, X Poiré, Koen Theunissen, Carlos Graux, et al.
Pages: 1434-1442 - Mesenchymal stem cells in multiple myeloma(2018)
Authors: Song Xu, Kim De Veirman, Ann De Becker, Karin Vanderkerken, Ivan Van Riet
Pages: 1500-1514 - Induction of miR-146a by multiple myeloma cells in mesenchymal stromal cells stimulates their pro-tumoral activity(2016)
Authors: Kim De Veirman, Jinheng Wang, Song Xu, Xavier Leleu, Eddy Himpe, Ken Maes, Elke De Bruyne, E Van Valckenborgh, Karin Vanderkerken, Eline Menu, et al.
Pages: 17-24